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Abstract Type-2 Diabetes mellitus and periodontal disease are complex human 
diseases. Pathogenesis of both ailments is multi-factorial, taking chronic disease 
courses with varied clinical presentations. It is well established in the scientific 
literature that both diseases are interrelated, in particular, individuals suffering from 
diabetes are at higher risk of developing periodontitis. The present review analyzed, 
using a hypothetical model, the complex factors which may indirectly influence the 
two diseases, including lifestyle, obesity, diabetes control, oral health behavior and 
serum inflammatory factors, and even quality of life. Special attention was given in 
this review to explore plausible theoretical or practical explanations of the 
interrelations and the contemporary evidence base underpinning these. As the societal 
burden of both diabetes and periodontitis are high, while individual general or oral 
health quality of life impacts are substantial, it is very important for healthcare 
professionals to appreciate the influence of any relevant factors, appreciating and/or 
controlling these, which may assist management of both diseases in those affected, or 
prevent development of these two complex diseases and the negative impacts arising 
among the at risk individuals in various populations. 
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Introduction 
Periodontitis is complex human disease clinically expressed as chronic inflammation 
at tooth supporting structures resulting from interactions between subgingival plaque 
biofilm and susceptible host defense system. Diabetes mellitus (DM) is yet another 
human complex disease characterized by metabolic disorders leading to various levels 
of chronic hyperglycemia resulting from insufficient insulin production, ineffective 
insulin action or both.  Even though possible contributory interactions between 
diabetes and periodontitis have been established and the support for a bi-directional 
link appears to be rather clear, one needs to be aware that available scientific evidence 
supports controversies over the association between these two complex diseases. 
Clinical evidence has been presented in the literature supporting direct, indirect or no 
association between DM and clinical periodontal status.  The probable reason over 
these different findings of associations could be due to the complex and multi-
factorial nature of these two diseases, such as level of diabetic control,
1
 differences 
arising from different periodontal disease data collection protocols,
2
 and differing 
numbers of clinical subjects used in the studies.
3
  Due to the complex nature of these 
two diseases, there seem to be other factors indirectly associated, apart from the direct 
basic science mechanisms linking both diabetes and periodontitis. These other factors 
include general health behavioral, lifestyle and level of serum inflammatory 
mediators.
4
 
The effect of periodontitis on general health quality of life remains ill-defined 
despite having been studied. Type-2 DM subjects however, were reported to 
experience dry mouth and in general had inferior physical, role and social 
functioning.
5
 The same study indicated other than type-2 DM, dry mouth, 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 4 
dissatisfaction with mouth or teeth and poor financial status were significantly 
associated with inferior general life quality among the 204 Scandinavians surveyed. 
The associated health behavior and lifestyle factors that play major roles in 
development of both the type-2 DM and periodontal disease could be general health 
behavior, diet and obesity, oral health behavior, psychological factors and their 
associations with serum inflammatory factors such as tumor necrosis factor alpha 
(TNF-α), respectively. The factors, established, theoretical or conceptual, that may 
contribute to type-2 diabetes, and periodontitis and their interactions, and may 
potentially modify the corresponding disease(s) outcomes are summarized (Fig. 1). 
The aim of this present review is to summarize the clinical evidence available 
reporting the associations between the above factors with both type-2 DM and poor 
periodontal health.  In particular, attention is drawn to the interactions between these 
two diseases and the aspects that healthcare professional should play attention to in 
attempting to promote good general and oral health for those who are affected. 
 
The general health behavior 
The optimal general health behavior is defined as not smoking, consuming fewer than 
ten alcoholic drinks per week if male, and fewer than five if female, always wearing a 
seatbelt in a car whether as a driver or as a passenger, participating at least three times 
a week in an exercise activity such as brisk walking, aerobics, sports, or heavy house-
work.
6
 Healthy general health behavior measured in terms of smoking, alcohol 
consumption, eating breakfast, hours of sleep, hours of work, physical exercise, 
nutritional balance, and mental stress are associated with higher natural killer cell 
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 5 
activity, which constitutes the first line of immunological defense.
7
 A healthier life 
style and fewer micro-vascular complications have been shown to be associated in 
diabetic males with higher education.
8
 Among diabetic women, however the more 
educated perceived themselves as healthier than those with less education, regardless 
of their concurrent medical status.
9
 Diabetic patients with poor metabolic control 
associated with a lower educational level, report more complications, nervous 
problems, sick leave days, disability pensions and lower level of physical activity than 
patients in good or acceptable metabolic control.
10
 Females with diabetes and of low 
social class faced a higher risk of mortality than did both non-diabetic females and 
diabetic males of low social class.
11
  
 Poor general health behaviors, regardless of DM status, on the other hand, 
were shown to be moderately associated with poor periodontal conditions,
12
 while 
those who maintained normal weight, engaged in regular exercise, and had a high-
quality diet experienced less periodontitis.
13 
 
Diet and Obesity 
Obesity is defined as excess body weight with an abnormally high proportion of body 
fat. Body mass index (BMI) is a simple measure of weight for height that correlates 
with body fat and is used to identify overweight and obesity.  Body mass index is 
defined as weight in kilograms divided by height in meters squared. The World 
Health Organization (WHO) committee and The National Institute of Health defined 
overweight as a BMI of 25 to 29.9 kg/m
2
 and obesity as a BMI of 30 kg/m
2 
or higher. 
BMI cutoffs are based on data showing that health risks increase beginning at a BMI 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 
 6 
of 25 kg/m
2
.
14
 The current increase in prevalence of obesity has been associated with 
an increase in the prevalence of type-2 diabetes.
15 
 Obesity is a known risk factor for type-2 diabetes, heart disease, stroke, 
hypertension, osteoarthritis, sleep apnea, and some forms of cancer.
16
 Overweight or 
obesity was the single most important predictor of type-2 diabetes.
17
 The risk of 
diabetes increases approximately 9% with every kilogram increase in self-reported 
weight
18
 and 4.5% with every kilogram increase in measured weight.
19
 Duration of 
obesity was also positively associated with the development of type-2 diabetes.
20
 
Obesity is associated with increase in insulin resistance and glucose intolerance, and 
exacerbates metabolic abnormalities present in type-2 diabetes, such as 
hyperinsulinemia, hyperglycemia and dyslipidemia. The expression in and secretion 
from adipose tissue of the pro-inflammatory cytokine serum TNF-α is elevated in 
obesity, and this may have a role in the insulin resistance of obesity and type-2 
diabetes.
21
 Adiponectin is another secretary product from adipose tissue that may be 
involved in the development of type-2 diabetes in susceptible obese individuals.
22
 
Obesity thus complicates the management of type-2 diabetes and makes it more 
difficult to treat the disease pharmacologically. An additional complication is that 
several of the agents used to treat type-2 diabetes, such as insulin, sulphonylureas, and 
thiazolidinediones, promote weight gain.
23
 Obesity thus increases morbidity and 
mortality of diabetes.
 
 Patients with type-2 diabetes treated in behavioral weight loss programs 
who reported the highest exercise levels lost the most weight and had the largest 
reductions in HbA1c, independent of weight loss at one year from pre-treatment.
24
 In 
persons with type-2 DM, exercise improves cardiopulmonary fitness, reduces blood 
glucose levels, improves insulin sensitivity, and reduces cardiovascular risk by 
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 7 
lowering blood pressure and improving dyslipidemia.
25
 Behavioral therapy programs 
generally resulted in modest weight loss.
24
  
 Obesity is claimed to be significantly associated with periodontal disease 
through the pathway of insulin resistance.
26
 The pro-inflammatory cytokine, serum 
TNF-α produced from adipose tissues in obese patients is known to play a 
predominant role in inducing insulin resistance.
27
 Conditions associated with obesity 
such as the metabolic syndrome may exacerbate periodontitis.
28
 Obesity has a 
significant association with periodontitis in terms of BMI, body fat, and maximum 
oxygen consumption.
29
 However, the association is limited to younger obese 
populations with increased prevalence of periodontal disease,
30
 and periodontal 
disease is positively associated with total cholesterol and low density lipoprotein 
cholesterol.
31
 Long term observational studies also showed increased weight and 
obesity to be positively associated with progression of periodontal disease
32
 and 
severity of probing pocket depths.
33
 The progression of periodontal disease also 
seems to be correlated with diagnosed overweight and obesity of at least 5 years, 
indicating the dose dependent nature of their association.
34 
 
Psychological factors 
Depression and psychosocial factors are considered as risk factors for both type-2 
DM
35
 and periodontal disease.
36
 Older women seem to suffer more from depression 
than men.
37
 Although the highest rates of depression are found among people under 
the age of 45, older adults are more likely to be prescribed antidepressants.
38
 
Prolonged negative events may disturb the optimal functioning of host defenses, 
consequently individuals experiencing stress have the potential to develop chronic 
diseases.
39
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 8 
Stress and depressive symptoms have been shown to be predictive regarding 
incidence of type-2 diabetes.
36
 The possible mechanisms include influence of 
depressive symptoms on behaviors such as physical activity and diet
40
 or their 
influence on the activity of hypothalamic-pituitary-adrenal axis and sympathetic 
nervous systems.
41
 The odds of type-2 diabetes increased by about 13% with addition 
of each negative stressful life event.
42
 It was also reported that stressful life events 
related to finance and work are indicators of poor metabolic health.
43 
An underlying bio-behavioral mechanism of stress impact on progression of 
periodontal disease has been suggested to act through two pathways. Stress may 
activate several neuroendocrine systems including the hypothalamic-pituitary-adrenal 
axis and the sympathetic nervous system leading to a reduced potential of the host 
defense,
44
 or may affect the development of the disease through lifestyle factors such 
as smoking.
45
 Increased work and psychological stress is associated with poor oral 
health status.
46
 The psychosocial measures of stress associated with financial strain 
and distress manifest as depression are associated with severe periodontal disease in 
the absence of adequate coping behavior, suggesting that the effects of stress on 
periodontal disease can be moderated by adequate coping behaviors.
39 
Dental anxiety 
is also associated with periodontal attachment loss
47
 and numbers of teeth with 
probing depths more than 6mm, and furthermore satisfaction with life is reported to 
be associated with flossing frequency.
48
 Chronic job and financial strain, depression 
and inadequate coping are all associated with risk of increased clinical attachment 
loss.
37
 This associated between stress and depression is mediated largely through the 
behavioral and physiologic mechanisms.
49
 Psychological stress is also associated with 
periodontal disease resistant to periodontal treatment,
50
 whereas depression is 
associated with tooth loss and chronic conditions associated with pain.
51
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Diabetic control 
With proper control of type-2 DM, therapists and patients can minimize the health 
risks and burdens for affected individuals and society. It is recently advocated by the 
International Diabetes Federation (IDF), based on the available evidence, that an 
HbA1c level of <7.0% is generally compatible with low diabetes related micro-and 
macro-vascular complications.
52
 An IDF treatment algorithm was proposed to the 
medical team in achieving the target <7.0% HbA1c taking into consideration of the 
local availability, access and cost of therapeutic agents.
53 
 Other than the diabetologist or endocrinologist, general medical practitioner, 
dietitian, exercise or fitness trainer, podiatrist, ophthalmologist, dentists/hygienist and 
periodontist are key team members to promote and maintain overall health of those 
affected by DM or even a pre-diabetic state.
54, 55
 Study following up such 
collaborative comprehensive care have confirmed that favorable DM management 
outcomes can be achieved.
56
 Obviously, to be successful in controlling type-2 DM, a 
comprehensive approach appears essential because it remains arguable that oral 
intervention alone could improve glycemic control.
57 
 
Oral health behavior 
The optimal oral health behavior is considered as visiting a dentist at least once a year 
for an examination other than for a dental problem, at least daily tooth brushing, using 
an inter-dental device such as flossing daily, wooden tooth pick once or more per day, 
no snacking between meals, and consuming no more than one cariogenic food a day.
6
 
Physical activity is positively associated with tooth brushing behavior, while alcohol 
consumption and smoking correlated negatively with proper oral health behavior.
58
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 10 
The frequency of tooth brushing is negatively correlated with sugar consumption 
among adolescents
58
 and is a predictive indicator of general health behavior.
59
 Poor 
oral health behaviors affected the periodontal status through the accumulation of 
plaque and calculus deposits.
4 
 Good oral hygiene habits, on the other hand, are positively associated 
with healthy food consumption, use of vitamins and regular physical exercise among 
adolescents.
60
 It was also reported that diabetic subjects generally show poor oral 
health behaviors, however absence of a control group negated the test of association 
between poor oral health behavior and type-2 diabetes mellitus.
61
 Nevertheless, 
systemically healthy non-diabetic periodontitis subjects were reported to have a 
significantly higher mean fasting blood glucose level.
62 
 
Serum inflammatory factors 
A few inflammatory mediators or related serum molecules such as interleukin-1 beta 
(IL-1β), IL-6, TNF-α, C-reactive protein (CRP), intercellular adhesion molecule 1 
(ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), are reported to be 
associated with both type-2 DM and chronic periodontitis. 
The pro-inflammatory cytokine TNF-α, is involved in the development of 
obesity linked insulin resistance
21
 through inhibiting tyrosine kinase activity at insulin 
receptors. Phosphorylation of the insulin receptor by this tyrosine kinase is known to 
be a cardinal step in the post-receptor events that follow the binding of insulin to its 
receptor and interferes with the insulin signaling cascade. The normal level of serum 
TNF-α is 0.72 ±0.28 pg/ml. In diabetes mellitus, TNF-α production was found to be 
increased
63
 and TNF-α plasma levels seems to be positively associated to metabolic 
control.
11
 High levels of serum TNF-α in patients with insulin resistance may be due 
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to high levels of fasting insulin.
64
 The production and activity of serum TNF-α is 
modulated by several oral anti-diabetic agents.
65
 Beside these relationships between 
serum TNF-α, metabolic control, anti-diabetic therapy and aging seems to be 
associated with an increase in serum TNF-α plasma levels.66 This increase in serum 
TNF-α levels with aging may be due to age associated increase in percentage of body 
fat.
67
 The levels of serum TNF-α were observed to become lower with weight loss.68  
More recently, the cause and effect relation between pro-inflammatory 
cytokines such as IL-1, TNF-α and periodontal attachment loss has been established.69 
The cellular source of serum TNF-α in periodontal diseases include, monocytes, 
polymorphonuclear leukocytes, fibroblasts, epithelial cells, endothelial cells, and 
osteoblasts. Once critical levels of pro-inflammatory cytokines production are reached, 
a local physiologic process becomes a pathologic response.
70
 The increased serum 
TNF-α in turn may exacerbate preexisting periodontal conditions by stimulating 
fibroblasts to synthesize matrix degrading enzymes,
71
 or by stimulating osteoclasts to 
activate bone resorption.
72
 Serum TNF-α can also induce expression of other 
mediators that amplify or sustain inflammatory responses, such as prostaglandins, and 
the production of lytic enzymes, and can also enhance bacterial killing and phagocytic 
activity
73
 and over production of serum TNF-α.70 Further synergistic action with IL-1 
can enhance bone resorption.
74
 Successful periodontal management decreases 
circulating serum TNF-α.75 Additionally, the reduction in circulating serum TNF-α is 
correlated with an improvement in metabolic control of diabetes, possibly mediated 
through an improvement in insulin resistance.
76
 
Along with pro-inflammatory cytokines, like TNF-α, other inflammatory 
mediators such as C-Reactive Protein (CRP) and IL-6 also play a major role in 
development of impaired glucose intolerance prior to the diagnosis of type-2 
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diabetes.
77
 Probing pocket depths and clinical attachment loss are also linearly 
associated with impaired fasting glucose levels before development of type-2 
diabetes.
78
 It has also been reported that increased inflammatory markers such as CRP, 
matrix metalloproteinases-14 (MMP-14) and tissue inhibitor of matrix 
metalloproteinases-2 (TIMP-2) are involved in progression of periodontal 
inflammation associated with type-2 diabetes.
79 
 
General and oral health related quality of life 
Obesity and diabetic complications are reported to be the main factors associated with 
inferior health related quality of life (HRQoL),
80
 while dissatisfaction of mouth and 
teeth and feeling of dry mouth were report to be affecting the HRQoL of type-2 DM 
subjects.
5
 So far reports remain scarce regarding the oral health related quality of life 
(OH-QoL) for DM subjects. One recent report indicated that dental caries and 
xerostomia conferred negative impacts on the OH-QoL of adolescents with type-1 
DM.
81
 The negative impact of advanced periodontal attachment loss in poor OH-QoL, 
however, was established.
82
 Based upon the fact that type-2 DM subjects would 
experience more periodontitis,
83
 it is fair to anticipate type-2 DM subjects may have 
inferior OH-QoL because of dry mouth and poor periodontal health. Further studies 
are needed to investigate such relationship. 
 
Type-2 diabetes and periodontal diseases 
Periodontal disease has been considered as the sixth complication of diabetes
84
 and 
diabetes mellitus is considered as risk factor for periodontal disease.
85
 However, the 
association between diabetes and periodontal disease is complex and to some extend 
controversial as the evidence has been advanced both for and against the association 
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 13 
between diabetes and periodontal disease. Emerging evidence portrays the association 
as bi-directional
86
 as compared to the other belief of unidirectional association,
87
 in 
which severe periodontitis is considered as a risk of poor glycemic control.
88
 The 
association between these two complex diseases can be explained by two similar but 
distinct pathologic pathways, a direct causal association in which the consequences of 
diabetes act as modifiers of periodontal disease expression
89
 or alternatively a 
common pathologic defect which results in a host susceptible to either or both 
diseases.
90 
The prevalence of diabetes in patients with periodontitis is double (12.5%) 
that seen in non-periodontitis patient (6.3%),
91
 even though no difference is detected 
in the number of etiologic factors or in the degree of gingival changes between the 
diabetic and control groups. However patients with poorly controlled diabetes suffer 
more from gingival bleeding than those with good or moderate control.
1
 Calculus and 
poor metabolic control were thought to be the best predictors for probing depth; 
patients with poor metabolic control and calculus has a higher prevalence of and more 
extensive periodontal pockets than well or moderately controlled diabetics.
92
 
Metabolic control seems to be less important in terms of association with attachment 
loss in the absence of calculus.  
Age and number of standing teeth were reported to significantly associated 
with periodontal attachment loss.
2
 Good or moderate control of any complex human 
disease is attributed to patient cooperation. Patients with well controlled diabetes 
might also be more cooperative regarding their oral health care habits and dental 
care.
13
 Clinical attachment loss is more severe in diabetics compared to non-diabetics. 
Diabetics with poorly controlled diabetes experience greater attachment loss 
compared to well controlled diabetics.
93
 Diabetic men have poorer periodontal status 
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than non-diabetic men.
94
 Diabetic women have poorer periodontal status than non-
diabetic women.
95
 Further, diabetic patients aged 55-74 have more severe periodontal 
disease than patients aged 45-54 and 75-90 and comparable age matched non 
diabetics.
3 
A long duration of diabetes is also considered as a risk factor for periodontitis.
 
An association between longer duration of diabetes and severity of attachment loss 
has been observed.
12
 This correlation is similar to that of other complications of 
diabetes, such as retinopathy and vascular disease.  
 Oral hygiene instructions were able to exert a positive effect on fasting 
blood glucose levels, gingival crevicular fluid volume, community periodontal index 
recordings and plaque index.
96
 Mechanical non-surgical periodontal treatment is also 
reported by a recent meta-analysis to be able to assist reduction of the glycated 
hemoglobin levels in the blood.
97
 Surgical periodontal treatment responses in 
diabetics were no different to those in age and sex matched non-diabetics.
98
 
Meanwhile, glycemic control has a positive influence on the gingival inflammation 
condition. It had been demonstrated that there was reduction of inflammation along 
the gingival margin with the improvement of glycemic control, even no periodontal 
intervention had been provided.
99 
 
Interrelationship between type-2 DM and periodontitis – a simplified model 
So far it seems that researchers are able to decipher only part of the theoretical 
relationship between type-2 DM and periodontitis. To a limited extent, certain 
behavioral and basic science interrelations between these two complex human 
diseases appears better appreciated (Fig. 2)
3
 and hopefully appropriate intervention 
aimed at changing key elements of the system may assist management of both type-2 
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DM and periodontitis. However, there remain substantial knowledge gaps, in 
particular the common pathogenic mechanisms between diabetic complications and 
periodontitis causation, as well as how impaired general and oral health life quality 
could at the end affect the behavior, and hence the compliance of affected individuals 
for  diabetic control and periodontal health maintenance. 
 
Conclusions 
The scientific evidence presented demonstrates the association between poor type-2 
diabetic status and poor periodontal health. This relationship seems to be influenced 
by complex and multifactorial nature of both the diabetes and periodontitis. Apart 
from the common pathogenesis pathways of periodontitis and diabetic complications 
such as impaired immune responses and poor wound healing, other factors including 
lifestyle, obesity and psychological factors could potential negatively influence local 
as well as systemic inflammatory mediators, which in turn may indirectly lead to poor 
diabetic control and periodontal destruction. It is therefore important to understand 
the indirect associations between lifestyle, obesity and psychological factors for both 
the type-2 diabetes and periodontal disease, as the modification of these modifiable 
factors greatly improves the management and prevention of both type-2 diabetes and 
periodontal disease in our communities. 
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Legend 
Figure 1 Simplified conceptual model regarding interactions between type-2 
diabetes mellitus and periodontitis pathogenesis and diseases outcomes. 
 
Figure 2 Possible behavioral and basic science interrelatedness between type-2 
diabetes mellitus and periodontal disease. A model modified from Kawamura et al.
4
 
highlighting possible area for disease intervention. 
 
 


